SSI is a public enterprise under the Danish Ministry of Health. For more than 100 years SSI’s main task has been to secure the preparedness towards infectious diseases and congenital disorders. The tasks have been expanded, and today, SSI is an international research, production and service enterprise. 

Statens Serum Institut (SSI) is responsible for research-based health surveillance, rational use of IT in the Danish healthcare system and prevention and control of infectious diseases, biological threats and congenital disorders.

SSI’s tasks include:

• Collection and communication of data concerning the health status of the Danish population including financial and quality control data of the Danish healthcare system.
• Ensuring national frameworks and standards for e-Health in the Danish healthcare system and managing and developing IT systems for the Danish Ministry of Health.
• Surveillance and control of infectious diseases and congenital disorders.
• Reference laboratories for infectious, autoimmune, congenital and genetic diseases.
• Ensuring the supply of vaccines, other biological products and diagnostic services through production and procurement.
• Preparedness against biological terrorism.
• Research and development in the Institute’s areas of activity at an international level. 

SSI aims to ensure advanced control of infectious diseases, including new infections and biological threats.

The Institute also strives to be a highly regarded and recognized national and international research, production and service enterprise.